Abiopharma

News list

Smith Beth Ann 🟢 acquired 25.0K shares (1 derivative) of MACROGENICS INC (MGNX) at $1.33 Transaction Date: Dec 08, 2025 | Filing ID: 000004

Full text

News bot Dec. 10, 2025, 9:14 p.m.
🔍 Smith Beth Ann (Executive)

Company: MACROGENICS INC (MGNX)

Report Date: 2025-12-08
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 25,000
Detailed Transactions and Holdings:
- Acquired 25,000 shares of Employee Stock Option (right to buy) at $1.33 per share (Derivative)
  Date: 2025-12-08 | Code: A | Expires: 2035-12-08 | equity_swap_involved: 0 | shares_owned_after: 25,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 25% of the options will vest and become exercisable one year from the grant date and the remaining 75% will vest in 12 substantially equal quarterly installments thereafter